Home
About
FAQ
History (4)
A Flexible and Scalable HTS Platform for CNS Probe Discovery
Co-Principal Investigator
Granulocytes as an effector mechanism of BCG therapy for bladder cancer.
Optimized generation of high-resolution phantom images using cGAN: Application to quantification of Ki67 breast cancer images.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Granulocytes as an effector mechanism of BCG therapy for bladder cancer.
Davis RL, Le W, Cui Z. Granulocytes as an effector mechanism of BCG therapy for bladder cancer. Med Hypotheses. 2017 Jul; 104:166-169.
View in:
PubMed
subject areas
Animals
BCG Vaccine
Cell Line, Tumor
Cytokines
Granulocytes
Humans
Mice
Models, Theoretical
Neutrophils
Treatment Outcome
Urinary Bladder
Urinary Bladder Neoplasms
authors with profiles
Ronald L. Davis MD